Good Therapeutics is a discovery-stage biotechnology company that is developing protein-based drugs with regulated, context-dependent activity.
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | Digitalis ... | digitalisv... |
| - | 3x5 Partne... | 3x5partner... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 30.12.2021 | Series B | $8M | - | geekwire.c... |
| 21.05.2020 | - | $11M | - | geekwire.c... |
| 19.02.2019 | - | $11M | - | geekwire.c... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 07.09.2022 | Roche shel... | Roche announced Wednesday that... | - | - | medcitynew... |
| 07.09.2022 | Roche to a... | Seattle-based Good Therapeutic... | - | Charlotte ... | geekwire.c... |
| 30.12.2021 | Good Thera... | Good Therapeutics CEO John Mul... | - | Charlotte ... | geekwire.c... |
| 30.12.2021 | Good Thera... | SEATTLE, WA, Good Therapeuti... | - | - | vcnewsdail... |
| 21.05.2020 | Good Thera... | Good Therapeutics CEO John Mul... | - | Taylor Sop... | geekwire.c... |
| 19.02.2019 | Seattle bi... | Good Therapeutics, a new Seatt... | - | James Thor... | geekwire.c... |